Orange Book product · Brand (NDA)
TARCEVA
ERLOTINIB HYDROCHLORIDE
At a glance
Nov 18, 2004
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 18, 2004
21 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ERLOTINIB HYDROCHLORIDE
Strength
EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021743
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2024ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 203843 · CHARTWELL RX
- 2024ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 209267 · HETERO LABS LTD V
- 2022ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 216342 · EUGIA PHARMA
- 2021ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 214719 · ALEMBIC
- 2021ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 214366 · MSN
- 2020ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 091059 · TEVA PHARMS USA INC
- 2020ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 211083 · ACCORD HLTHCARE
- 2020ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 213065 · ZYDUS PHARMS
- 2019ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 208396 · APOTEX
- 2019ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 208488 · NATCO PHARMA LTD
- 2019ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 211960 · SHILPA
- 2019ERLOTINIB HYDROCHLORIDEGeneric (ANDA)
ANDA 210300 · SUN PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

